Martin Geroldinger

Dr. Martin Geroldinger

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2023 in Biometrical Journal
Verified
Journal Article
Open access
MGMartin Geroldinger
Martin Geroldinger
JVJohan Verbeeck
Johan Verbeeck
KTKonstantin E. Thiel
Konstantin E. Thiel
GMGeert Molenberghs
Geert Molenberghs
ABArne C. Bathke
Arne C. Bathke
GZGeorg Johannes Zimmermann
Georg Johannes Zimmermann
Ordinal data in a repeated measures design of a crossover study for rare diseases usually do not allow for the use of standard parametric methods, and hence, nonparametric methods should be considered instead. However, only limited simulation studies in settings with small sample sizes exist. Therefore, starting from an Epidermolysis Bullosa simplex trial with the above‐mentioned design, a rank‐based approach using the R package nparLD and different generalized pairwise comparisons (GPC) methods were compared impartially in a simulation study. The results revealed that there was not one single best method for this particular design, because a trade‐off exists between achieving high power, accounting for period effects, and for missing data. Specifically, nparLD as well as the unmatched GPC approaches do not address crossover aspects, and the univariate GPC variants partly ignore the longitudinal information. The matched GPC approaches, on the other hand, take the crossover effect into account in the sense of incorporating the within‐subject association. Overall, the prioritized unmatched GPC method achieved the highest power in the simulation scenarios, although this may be due to the specified prioritization. The rank‐based approach yielded good power even at a sample size of , whereas the matched GPC method could not control the type I error.

19 December 2023 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
MGMartin Geroldinger
Martin Geroldinger
JVJohan Verbeeck
Johan Verbeeck
AHAndrew C. Hooker
Andrew C. Hooker
KTKonstantin E. Thiel
Konstantin E. Thiel
GMGeert Molenberghs
Geert Molenberghs
GZGeorg Zimmermann
Georg Zimmermann
Background: Recommendations for statistical methods in rare disease trials are scarce, especially for cross-over designs. As a result various state-of-the-art methodologies were compared as neutrally as possible using an illustrative data set from epidermolysis bullosa research to build recommendations for count, binary, and ordinal outcome variables. For this purpose, parametric (model averaging), semiparametric (generalized estimating equations type [GEE-like]) and nonparametric (generalized pairwise comparisons [GPC] and a marginal model implemented in the R package nparLD) methods were chosen by an international consortium of statisticians. Results: It was found that there is no uniformly best method for the aforementioned types of outcome variables, but in particular situations, there are methods that perform better than others. Especially if maximizing power is the primary goal, the prioritized unmatched GPC method was able to achieve particularly good results, besides being appropriate for prioritizing clinically relevant time points. Model averaging led to favorable results in some scenarios especially within the binary outcome setting and, like the GEE-like semiparametric method, also allows for considering period and carry-over effects properly. Inference based on the nonparametric marginal model was able to achieve high power, especially in the ordinal outcome scenario, despite small sample sizes due to separate testing of treatment periods, and is suitable when longitudinal and interaction effects have to be considered. Conclusion: Overall, a balance has to be found between achieving high power, accounting for cross-over, period, or carry-over effects, and prioritizing clinically relevant time points.

16 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BWBenjamin Walch
Benjamin Walch
AGAlexander Gaggl
Alexander Gaggl
KZKatharina Zeman-Kuhnert
Katharina Zeman-Kuhnert
VRValentina Ranstl
Valentina Ranstl
MGMartin Geroldinger
Martin Geroldinger
FHFlorian Huber
Florian Huber
Background: Dysphagia and malnutrition are common among head and neck squamous cell carcinoma (HNSCC) patients. Evidence and guidelines emphasize treatment and prevention of these conditions before surgery. In this context, multimodal prehabilitation (MP) is an essential part of a holistic treatment approach. However, the specific components and their relative importance remain debated. This study aimed to evaluate the impact of nutritional, logopedic and psychological MP. Methods: Adult HNSCC patients who completed the German version of the Functional Assessment of Cancer Therapy—Head and Neck (FACT-H&N) quality-of-life (QOL) questionnaire after undergoing curative resection and reconstructive surgery were included in this cross-sectional study. Clinical data on psychological, logopedic and nutritional MP and possible confounders was collected. To evaluate the nutritional status, bodyweight loss, the body mass index (BMI) and the Graz Malnutrition Screening (GMS) score were recorded. We determined the length of stay (LOS), the QOL, the Clavien–Dindo type III and IV complication rate (CR) as the outcome parameters for MP. Results: In total, 102 patients were included. Of those, 68 were male, while the other 34 were female. The mean age was 59.82 ± 12.27 years. The average GMS was 3.11 ± 1.45. Simultaneously, 62.75% of patients were at risk or malnourished. Malnutrition was significantly associated with adverse outcomes in the univariate, but only with decreased QOL in the multivariate model. On the other hand, MP was significantly associated with reduced LOS and improved QOL. These findings remained robust even after adjustment for possible confounders. Neither had a significant effect on the CR. Conclusions: Our findings suggest that malnutrition is a potential risk factor for adverse outcomes in curative HNSCC therapy. The GMS is a sensitive tool for identifying patients at risk of malnutrition in HNSCC surgery prehabilitation. Our multimodal protocol was associated with improved postoperative outcomes following curative surgical resection and free flap reconstruction. The observed associations may reflect potential synergistic interactions within the multimodal framework.

Verified
Journal Article
Open access
PDF file
BWBenjamin Walch
Benjamin Walch
AGAlexander Gaggl
Alexander Gaggl
GBGian Battista Bottini
Gian Battista Bottini
JHJohannes Hachleitner
Johannes Hachleitner
FHFlorian Huber
Florian Huber
GMGoetzinger Maximilian
Goetzinger Maximilian
Background: Orbital floor blowout fractures (OFBF) can have serious consequences for the patient. Selecting the right treatment method and materials is essential. Krenkel’s maxillary sinus implant has been used successfully for more than 40 years in clinical practice. The aim of this study was to evaluate the long-term outcome of this implant compared to polydioxanone (PDS) sheets. Material and methods: This retrospective study examined a cohort of 82 OFBF patients over a seven-year period. Clinical and geometric data were collected. Defect size, location, and the volume of the herniated tissue were measured from conventional computer tomography (CT) or cone beam computer tomography (CBCT) scans. The relationship between ophthalmologic rehabilitation and treatment modality was analyzed using logistic regression. Results: The study included 82 patients, 28% female and 72% male, with a median age of 45.2 years. Defect size and hernia volume correlated with preoperative ophthalmological symptoms. At follow-up, 14.8% in the implant group and 28.6% in the PDS group showed mild visual impairment, with no severe diplopia. Conclusions: Our results suggest this method is a reliable and effective solution for repairing OFBFs and ophthalmologic rehabilitation. However, further research in a clinical controlled trial is needed.

21 September 2026 in Statistics in Medicine
Verified
Journal Article
Open access
MGMartin Geroldinger
Martin Geroldinger
MLMartin Laimer
Martin Laimer
VWVerena Wally
Verena Wally
JBJohann Bauer
Johann Bauer
GZGeorg Johannes Zimmermann
Georg Johannes Zimmermann
Multivariate endpoints are increasingly used in clinical studies on rare diseases, where sample sizes tend to be small and distributional assumptions are often violated. In such settings, commonly applied parametric multivariate methods, such as classical MANOVA approaches, may suffer from inflated type‐I error or reduced statistical power. Therefore, a neutral simulation‐based comparison of four methodologically different approaches for the analysis of multivariate outcomes in parallel group designs was conducted. The four approaches included the nonparametric R package npmv (using permutation and randomization resampling for small samples), a semiparametric MANOVA approach from the R package MANOVA.RM with both a Wald‐type statistics (WTS) and a modified ANOVA‐type statistics (MATS) using all available variants including also bootstrap approaches, a classical parametric MANOVA , and multiple univariate Mann–Whitney tests with Holm correction. The simulation framework was informed by empirical distributions derived from anonymized clinical data and clinical expert guidance. Two clinically realistic effect types were mainly evaluated: (i) percent‐responder effects for wound size reduction and (ii) additional location shifts in pain and pruritus visual analog scales (VAS) scores. In addition, scenarios are examined in which classical assumptions such as multivariate normality and homogeneity of covariance matrices are violated. The sample sizes considered ranged from 12 to 360 subjects. Both balanced and unbalanced designs were evaluated, with the objective of illustrating potential limitations of methods when applied to small samples. Outcomes were assessed in terms of type‐I error control and statistical power. Overall, npmv , the MATS using especially parametric bootstrap within the semiparametric MANOVA.RM package maintained reliable type‐I error control, whereas the semiparametric MANOVA.RM approach with the WTS using its asymptotic approximation showed very liberal type‐I error behavior to almost no type‐I error control in small sample scenarios, and especially in unbalanced settings. Bootstrap approaches especially of the WTS substantially improved type‐I error control compared with the asymptotic WTS. The nonparametric npmv approach achieved good power values, especially in small samples, as did the modified ATS approach using parametric bootstrap from the MANOVA.RM package, which achieved very similar results. The univariate Mann–Whitney U test with Holm correction tended to yield conservative results for small samples; however, despite the univariate nature of this approach, it achieved a high and comparable level of statistical power in many scenarios. Classical MANOVA also yielded good results in certain scenarios; however, it exhibited rather liberal type‐I error rates, primarily in heteroscedastic scenarios and unbalanced designs, which can be explained by a violation of the assumption of homoscedastic covariance matrices. These results highlight the strengths and limitations of a multi‐aspect analysis in parallel group designs especially for small sample settings, as common in rare diseases, and provide guidance for the analysis in rare disease research.

27 November 2025 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
SMSilvia Masnada
Silvia Masnada
Valentina De GiorgisValentina De Giorgis
Valentina De Giorgis
UCUmberto Carugo
Umberto Carugo
NBNadia Bahi-Buisson
Nadia Bahi-Buisson
MCMara Cavallin
Mara Cavallin
AAAlexis Arzimanoglou
Alexis Arzimanoglou